Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of CLAG-M in Relapsed ALL

NCT01513603 is registered in ClinicalTrials.gov with New York Medical College as lead sponsor.

NCT NCT01513603
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01513603 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of CLAG-M in Relapsed ALL
Lead sponsor
New York Medical College
Phase
Phase 2
Overall status
Unknown status
Start date
January 31, 2012
Completion date
January 31, 2014
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphoblastic leukemia, burkitts leukemia/lymphoma, chronic myelogenous leukemia, lymphoblastic lymphoma